04 February 2021 1 Min Read
BioNTech fund pays €600m to early backers after vaccine success
MIG has provided funding to the German biotech company, which developed the vaccine with US drugmaker Pfizer, since 2008
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In